Levetiracetam Actavis Group

Levetiracetam, the active ingredient in Levetiracetam Actavis Group, is an anticonvulsant presented as an oral formulation for oral use. It is prescribed to manage various seizure types in patients diagnosed with epilepsy. The medication works by modulating neurotransmitter release, helping to stabilize neuronal activity and reduce seizure frequency.

GNH USA supplies Levetiracetam Actavis Group as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. Our distribution network ensures consistent quality and regulatory compliance across multiple markets.

Levetiracetam is an antiepileptic agent used to treat several seizure disorders.

- Partial seizures: reduces the frequency and severity of focal onset seizures. - Generalized tonic‑clonic seizures: helps control convulsive episodes and lowers recurrence. - Myoclonic seizures: decreases the occurrence of sudden, brief muscle jerks.

Levetiracetam may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Dizziness - Fatigue - Somnolence - Headache - Irritability - Nausea

Serious or Rare Side Effects: - Severe allergic reactions (e.g., anaphylaxis, Stevens‑Johnson syndrome) - Mood changes, including depression or suicidal thoughts - Blood dyscrasias such as neutropenia or thrombocytopenia - Multi‑organ hypersensitivity reactions

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications.

- Renal impairment: adjust dose based on creatinine clearance. - Hepatic function: use caution in patients with liver disease. - Concomitant CNS depressants: monitor for enhanced sedation. - Pregnancy safety: data are limited; assess risk‑benefit. - Mood monitoring: observe for depression or suicidal ideation. - Store at ambient temperature: keep in the original container, protect from moisture.

Levetiracetam can interact with other medications, affecting its efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: strong enzyme inducer that lowers levetiracetam plasma levels. - Phenytoin: may reduce levetiracetam exposure. - Phenobarbital: decreases levetiracetam concentrations.

Moderate Interactions (Monitor Closely): - Valproic acid: can increase levetiracetam levels modestly. - NSAIDs: may enhance central nervous system side effects. - Oral contraceptives: monitor for potential reduced contraceptive efficacy.